Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 189.34M P/E - EPS this Y -31.50% Ern Qtrly Grth -
Income -28.37M Forward P/E -11.89 EPS next Y 4.20% 50D Avg Chg -12.00%
Sales 49.03M PEG -0.11 EPS past 5Y -26.87% 200D Avg Chg 43.00%
Dividend N/A Price/Book 5.25 EPS next 5Y 15.00% 52W High Chg -51.00%
Recommedations 2.50 Quick Ratio 4.27 Shares Outstanding 34.64M 52W Low Chg 318.00%
Insider Own 16.18% ROA -21.83% Shares Float 25.92M Beta 1.21
Inst Own 40.52% ROE -110.25% Shares Shorted/Prior 243.91K/296.91K Price 5.47
Gross Margin 61.90% Profit Margin -57.86% Avg. Volume 330,887 Target Price 3.50
Oper. Margin -45.66% Earnings Date Nov 7 Volume 144,705 Change -1.08%
About Apyx Medical Corporation

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Apyx Medical Corporation News
11/12/24 Apyx Medical Corporation to Attend 15th Annual Craig-Hallum Alpha Select Conference
11/10/24 Apyx Medical Third Quarter 2024 Earnings: EPS Beats Expectations
11/09/24 Apyx Medical Corp (APYX) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ...
11/08/24 Apyx Medical (APYX) Reports Q3 Loss, Lags Revenue Estimates
11/08/24 Apyx: Q3 Earnings Snapshot
11/08/24 Apyx Medical Corporation Announces $7,000,000 Million Registered Direct Offering
11/08/24 Apyx Medical Corporation Reports Third Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook and Introduces Full Year 2025 Financial Outlook
10/25/24 Apyx Medical Corporation to Release Third Quarter Of Fiscal Year 2024 Financial Results on November 8, 2024
10/15/24 Chuck Royce's Strategic Acquisition of Apyx Medical Corp Shares
10/09/24 Apyx Medical Corp (APYX) Q2 2024 Earnings Call Highlights: Navigating Revenue Declines and ...
10/03/24 Apyx (APYX) Upgraded to Buy: Here's What You Should Know
08/21/24 Apyx Medical Insiders Placed Bullish Bets Worth US$2.27m
08/13/24 Renuvion Named #1 Trusted Body Contouring Technology by Doctors*
08/08/24 Apyx Medical (APYX) Reports Q2 Loss, Lags Revenue Estimates
08/08/24 Apyx: Q2 Earnings Snapshot
08/08/24 Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Comparing the Use of Renuvion to a Competing Technology Following Liposuction or Body Contouring Procedures
08/08/24 Apyx Medical Corporation Reports Second Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook
07/25/24 At US$1.39, Is It Time To Put Apyx Medical Corporation (NASDAQ:APYX) On Your Watch List?
07/25/24 Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024
07/01/24 Calculating The Fair Value Of Apyx Medical Corporation (NASDAQ:APYX)
APYX Chatroom

User Image PenkeTrading Posted - 2 weeks ago

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Apyx Medical Inc. Is that bullish or bearish? $APYX #RsiOverbought #NASDAQ

User Image stklover Posted - 2 weeks ago

$APYX The weirdest stock I own. They do an offering, they miss the top and bottom numbers, but the stock trades up 25%

User Image 30DeltaSpy Posted - 2 weeks ago

$APYX bullish

User Image jParkz Posted - 2 weeks ago

$APYX News out Apyx Medical Corporation Reports Third Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook and Introduces Full Year 2025 Financial Outlook https://marketwirenews.com/news-releases/apyx-medical-corporation-reports-third-quarter-2024--6638725981208125.html $APYX

User Image Bangerplays Posted - 2 weeks ago

$APYX swing for the fences

User Image jParkz Posted - 2 weeks ago

$APYX News Apyx Medical Corporation Announces $7,000,000 Million Registered Direct Offering https://marketwirenews.com/news-releases/apyx-medical-corporation-announces-7-000-000-million-6202571665604960.html $APYX

User Image DonCorleone77 Posted - 2 weeks ago

$APYX Apyx Medical to sell 3M shares at $1.18 in registered direct offering Apyx Medical has entered into a definitive purchase agreement with Nantahala Capital for the purchase and sale in a registered direct offering of 3,000,000 shares of the Company's common stock at a purchase price of $1.18 per share and pre-funded warrants to purchase up to 2,934,690 shares of the Company's common stock at a purchase price of $1.179 per pre-funded warrant. The gross proceeds to Apyx Medical from the offering were approximately $7,000,000, before deducting offering expenses payable by the Company. The offering closed on November 8, 2024. The purchase price of $1.18 per share of common stock was calculated using the average closing price of the Company's common stock on the Nasdaq Global Select Market for the five trading days prior to market close on November 7, 2024. The Company did not use a placement agent in connection with the offering. Apyx Medical intends to use the proceeds from the offering for working capital and other general corporate purposes.

User Image breadbread Posted - 2 weeks ago

$APYX Apyx Medical cuts FY24 revenue view to $46.6M-$47.6M from $50.6M-$52.1M FY24 revenue consensus $50.77M

User Image DonCorleone77 Posted - 2 weeks ago

$APYX Apyx Medical sees FY25 revenue view to $47.6M-$49.5M, consensus $54.04M Total revenue in the range of $47.6 million to $49.5 million, representing growth of approximately 2% to 6% year-over-year, compared to $46.6 million the low-end of the updated total revenue guidance for the year ended December 31, 2024.

User Image DonCorleone77 Posted - 2 weeks ago

$APYX Apyx Medical cuts FY24 revenue view to $46.6M-$47.6M from $50.6M-$52.1M FY24 revenue consensus $50.77M

User Image DonCorleone77 Posted - 2 weeks ago

$APYX Apyx Medical reports Q3 EPS (14c), consensus (19c) Reports Q3 revenue $11.487M, consensus $11.38M. "While our Advanced Energy sales decreased year-over-year, we were pleased with the continued resiliency of our disposable handpiece, which grew 9% overall and 15% in the U.S. Looking ahead, we expect the strength of our disposable handpiece sales to continue, and expect to ship a total of nearly 90,000 units for the full year 2024," said Charlie Goodwin, President and Chief Executive Officer. "It has been a busy few months for us, as we initiated a cost reduction program, raised $7.0 million to strengthen the balance sheet, and amended the covenants with our lender and partner, which we believe will extend our cash runway and allow us to execute our growth strategy."

User Image jParkz Posted - 10/25/24

$APYX News Apyx Medical Corporation to Release Third Quarter Of Fiscal Year 2024 Financial Results on November 8, 2024 https://marketwirenews.com/news-releases/apyx-medical-corporation-to-release-third-quarter-of-8284922086232385.html $APYX

User Image stklover Posted - 1 month ago

$APYX Someone please just take this company out!

User Image Fullratio Posted - 1 month ago

$APYX price to sales (P/S) is 84% less than its 5-year quarterly average of 5.6 and 39% less than its last 4 quarters average of 1.5: https://fullratio.com/stocks/nasdaq-apyx/apyx-medical

User Image PenkeTrading Posted - 2 months ago

I found you an Oversold RSI (Relative Strength Index) on the daily chart of Apyx Medical Inc. Is that bullish or bearish? $APYX #RsiOversold #NASDAQ

User Image stklover Posted - 2 months ago

$APYX Seems like there is no interest in this stock. I own it for only one reason. Hoping someone buys them out. Not the greatest reason to own a stock, but sense this could be an opportunity for the right company to pick them off.

User Image Imran26 Posted - 08/29/24

$SSKN my analysis is fundamental, I am not tracking technical triggers. With revenue decline stopped, better margins and an endless market size, this could become one of the only aesthetic/clinical dermatology companies to survive and collect the pieces. On its own, analyst gave it a price target of $16. Once consolidation happens one could easily see a $150-200 million revenue with a lot of sales force synergies (e.g think about $BFRI $SRTS for two examples of in clinic procedure companies and $APYX and $CUTR for aesthetic dermatology players). All of these are struggling stand alone, but can co exist together.

User Image stklover Posted - 2 months ago

$APYX Interest rate sensitive micro-cap with a kicker of possible takeover candidate. $2 easy!

User Image JackDarwin Posted - 3 months ago

$APYX Bullish Engulfing Formed.

User Image stklover Posted - 3 months ago

$APYX Sleeper stock ready to take off

User Image smokyfutures Posted - 3 months ago

$APYX CFO buys are usually legit.

User Image insiderbuyingselling Posted - 3 months ago

$APYX new insider buying: 5336 shares. http://insiderbuyingselling.com/?t=APYX

User Image epsguid Posted - 3 months ago

$APYX reported a loss of $0.19, consensus was ($0.18) via @eWhispers #epsmiss http://eps.sh/d/apyx

User Image Stock_Titan Posted - 3 months ago

$APYX Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Comparing the Use of Renuvion to a Competing Technology Following Liposuction or Body Contouring Procedures https://www.stocktitan.net/news/APYX/apyx-medical-corporation-announces-peer-reviewed-clinical-ndtsjwc4uqki.html

User Image Stock_Titan Posted - 3 months ago

$APYX Apyx Medical Corporation Reports Second Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook https://www.stocktitan.net/news/APYX/apyx-medical-corporation-reports-second-quarter-2024-financial-ukc90vrucn54.html

User Image NVDAMillionaire Posted - 07/31/24

$APYX Apyx Medical Corporation: Navigating Headwinds, Positioning for Long-Term Growth http://beyondspx.com/2024/07/30/apyx-medical-corporation-navigating-headwinds-positioning-for-long-term-growth/

User Image Stock_Titan Posted - 07/25/24

$APYX Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024 https://www.stocktitan.net/news/APYX/apyx-medical-corporation-to-release-second-quarter-of-fiscal-year-a6l23ddrutgp.html

User Image TickerDD_com Posted - 4 months ago

From 6/14/2024, looking back across 21 Month-Ends for APYX, Percentage Change of Average Monthly Price had Equal (50%) while Percentage Change of Average Monthly Volume had All Positives (100%) $APYX #APYX #APYXStock #TickerDD #APYXPrice https://www.youtube.com/watch?v=-tqcuATAk6c

User Image NVDAMillionaire Posted - 4 months ago

$APYX Apyx Medical Corporation (NASDAQ:APYX): Navigating Challenging Market Conditions with a Robust Product Pipeline http://beyondspx.com/2024/06/30/apyx-medical-corporation-nasdaqapyx-navigating-challenging-market-conditions-with-a-robust-product-pipeline/

User Image stockcloud Posted - 6 months ago

$CTXR $EOSE $WTI $APYX $SAI - Potential reversal - Needs volume . Watch into today/next week. GLTA:-)

Analyst Ratings
JMP Securities Market Perform Sep 16, 24
Stephens & Co. Overweight Nov 10, 23
Piper Sandler Overweight Aug 11, 23
Stephens & Co. Overweight Jul 14, 23
Lake Street Buy Jun 15, 23
JMP Securities Market Perform May 24, 23
Lake Street Buy May 12, 23
Piper Sandler Overweight Aug 12, 22
Lake Street Buy Jul 19, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
HILL MATTHEW C Chief Financial Offi.. Chief Financial Officer Dec 12 Buy 2.19 2,500 5,475 2,500 12/14/23
Geraghty Michael Director Director Jun 06 Option 2.79 10,000 27,900 27,500 06/09/23
Goodwin Charles D. II Chief Executive Offi.. Chief Executive Officer Aug 29 Buy 5.95 11,750 69,912 40,000 08/31/22
CITRONOWICZ MOSHE Sr. V.P. of Operatio.. Sr. V.P. of Operations Jul 11 Option 2.54 30,000 76,200 456,504 07/12/22
Waldman Lawrence Director Director Jul 11 Option 2.54 24,000 60,960 37,563 07/11/22
Geraghty Michael Director Director Jul 06 Option 2.54 4,000 10,160 17,500 07/11/22
Waldman Lawrence Director Director May 19 Option 2.79 8,000 22,320 13,563 05/23/22
Geraghty Michael Director Director May 11 Option 2.79 6,000 16,740 13,500 05/19/22
Swandal Craig A. Director Director Mar 21 Option 4.98 17,000 84,660 17,000 03/22/22